Breaking News

Hi-Tech Pharmaceuticals Expands Production Capabilities

Adds tablet presses to increase production of large tablets for its Cyclosome Technology and Guaifenesin OTC drug products.

Hi-Tech Pharmaceuticals has added four more Stokes 328 tablet presses to increase production of large tablets for its Cyclosome Technology and Guaifenesin OTC drug products. Two presses will be dedicated to the weight management product SLIMAGLUTIDE and Cyclosome products. The other two presses will be for the company’s Ameripharm brand of OTC products. It will also partner with store brand products to sell a generic version of Mucinex tablets.

According to the company, the treatment, which will bolster the availability of what is expected to be a range of new, generic store brand cough and mucus-suppressant products, will be packaged, and sold under retailers’ own labels and the Ameripharm line of OTC products.

“This is another great example of the Hi-Tech and Ameripharm teams continuing to leverage their unique capabilities in providing U.S. consumers greater savings and access to key new store brand over-the-counter products,” said Jared Wheat, CEO Hi-Tech. “These new store brand products, which are equivalent to the Mucinex brand, are an important offering to our customers as they deliver high-quality, value alternative available in the marketplace with significant volumes.”

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters